Introduction
============

According to Globocan, a total of 18.1 million new cancer cases and 9.6 million cancer-related deaths occurred in 2018 ([@b1-ol-0-0-11698]). Both in men and women, lung cancer is the most commonly diagnosed cancer (11.6% of total cases) and the leading cause of cancer-related death (18.4% of all cancer-related deaths) ([@b1-ol-0-0-11698]). It is estimated that \~80% of lung cancer cases are non-small cell lung cancer (NSCLC), and \~50% of NSCLC are adenocarcinomas ([@b2-ol-0-0-11698]). In recent years, radiotherapy has been a critical therapeutic approach for lung cancer. However, both recurrence and metastasis after radiotherapy remain life-threatening complications of cancer and are primarily responsible for cancer patient mortality ([@b3-ol-0-0-11698]). Therefore, elucidating the mechanism of radiation damage is crucial for radiotherapy of lung cancer.

Circular RNA (circRNA) is a broad category of non-coding RNA characterized by a covalently closed ring framework without 5′-3′ polarity ([@b4-ol-0-0-11698]--[@b7-ol-0-0-11698]). Unlike other forms of RNA, circRNA not only exists in organisms stably but also has resistance to RNase R treatment ([@b8-ol-0-0-11698]--[@b10-ol-0-0-11698]). Although Sanger *et al* ([@b11-ol-0-0-11698]) first identified circRNA in viruses in 1976, its functions in various diseases have only been recently reported. With the development of new biochemical and computational methods, circRNA has attracted increasing research attention ([@b5-ol-0-0-11698],[@b12-ol-0-0-11698]). Previous studies demonstrated that circRNAs regulate mRNA transcription via two main mechanisms: Competition with mRNAs leading to inhibition of host gene expression ([@b13-ol-0-0-11698]), and elimination of the inhibitory effects of microRNA (miRNA/miR) on target genes by acting as miRNA sponges ([@b5-ol-0-0-11698],[@b14-ol-0-0-11698]).

Several previous studies suggested that circRNAs were involved in various human diseases, such as lupus nephritis ([@b15-ol-0-0-11698]), cardiovascular diseases ([@b16-ol-0-0-11698]) and systemic neural diseases ([@b17-ol-0-0-11698]). The role of circRNAs in human cancer was also previously examined. For instance, hsa_circ_002059 could be a potential novel and stable biomarker for the diagnosis of gastric carcinoma ([@b18-ol-0-0-11698]). circRNA-000911 might regulate the carcinogenesis of breast cancer ([@b19-ol-0-0-11698]). Furthermore, circRNAs could promote cell proliferation, migration, invasion and metastasis in NSCLC ([@b20-ol-0-0-11698]--[@b22-ol-0-0-11698]). Moreover, previous studies have suggested that circRNA may play an importantly regulatory role in radiation-induced esophageal injury ([@b23-ol-0-0-11698]). circRNA was significantly differentially expressed in radioresistant esophageal cancer cells ([@b24-ol-0-0-11698]) and radioresistant HeLa cells ([@b25-ol-0-0-11698]). circRNA_014511 could affect the radiosensitivity of bone marrow mesenchymal stem cells by binding to miR-29b-2-5p ([@b26-ol-0-0-11698]). However, the circRNA expression profiles of NSCLC cells in response to radiation treatment remain unclear.

The present study, investigated for the first time to the best of the authors\' knowledge, the regulation of circRNAs in irradiated and non-irradiated A549 cells using high-throughput RNA sequencing (RNAseq). The expression levels of dysregulated circRNAs were also verified by reverse transcription-quantitative PCR (RT-qPCR), and the application and function of dysregulated circRNAs in disease diagnosis were assessed. Overall, the present study suggested that circRNAs could play an important role in lung cancer radiotherapy.

Materials and methods
=====================

### Cell culture

The human NSCLC cell lines A549 and NCI-H1299 were purchased from The American Type Culture Collection and were authenticated by STR DNA profiling analysis. NSCLC cells were cultured in RPMI-1640 medium (GE Healthcare) containing 10% FBS (Thermo Fisher Scientific, Inc.) and 5 mg/ml penicillin/streptomycin (Thermo Fisher Scientific, Inc.) at 37°C with 5% CO~2~. NSCLC cells were digested and passaged every 3 days by using EDTA-containing trypsin (Thermo Fisher Scientific, Inc.).

### Irradiation

A549 cells were plated at 1×10^4^ cells/well in 96-well plates. After incubation for 24 h, A549 cells were exposed to various doses (0, 2, 4 and 8 Gy) of irradiation using the X-RAD 160--225 instrument (42 cm; 225 kV/s; 12.4 mA; 2.0 Gy/min; filter, 2 mm aluminum; Precision X-Ray, Inc.) ([@b27-ol-0-0-11698],[@b28-ol-0-0-11698]). Radiosensitivity was assessed after treatment with the irradiation for 24 h or 48 h.

### Cell Counting Kit-8 (CCK-8) assay

Following irradiation, cell proliferation was measured by CCK-8 according to the manufacturer\'s instructions. The CCK-8 kit was purchased from Beyotime Biotechnology Co., Ltd. The 450 nm absorbance (630 nm reference) was determined for each well, using a Multiskan™ FC Microplate Photometer (Thermo Fisher Scientific, Inc.). Each experiment was repeated three times.

### Total RNA extraction

Total RNA was extracted using the Total RNA extraction kit (Beijing Solarbio Science & Technology Co., Ltd.), according to the manufacturer\'s instructions. RNA concentration and purity were determined using a NanoDrop™ 2000 spectrophotometer (Thermo Fisher Scientific, Inc.). RNA integrity was assessed by 1% formaldehyde denaturing gel electrophoresis. The total RNA of the control group cells (0 Gy/48 h) and the irradiation group cells (2 Gy/48 h) were extracted separately for RNAseq, three samples per group.

### circRNA sequencing analysis

RNA libraries were constructed by CloudSeq Pte Ltd. circRNA sequencing analysis was also performed by CloudSeq Pte Ltd according to the manufacturer\'s instructions ([@b14-ol-0-0-11698]). Cluster and TreeView were used to conduct hierarchical clustering analysis using R (v3.6.3) ([@b29-ol-0-0-11698]) in order to assess differential expression of circRNAs in irradiated and non-irradiated A549 cells. These circRNAs that can be found in the circbase (<http://www.circbase.org/>) are known circRNAs, and those that cannot be found are novel circRNAs. DCC (detect circRNAs from chimeric reads, v0.4.4) software was used to detect circRNAs from chimeric reads. The functional roles of target genes in biological process (BP), cellular component (CC) and molecular function (MF) were examined through Gene Ontology (GO) (current release 2020-03-24, <http://geneontology.org>) analysis. The involvement of genes encoding circRNAs in biological pathways was assessed by the Kyoto Encyclopedia of Genes and Genomes (KEGG) using the Database for Annotation, Visualization and Integrated Discovery v6.8 (<https://david.ncifcrf.gov/>).

### RT-qPCR

circRNA expression profiles obtained from high-throughput sequencing were verified by RT-qPCR. Total RNA was extracted from cells using the Total RNA extraction kit (Beijing Solarbio Science & Technology Co., Ltd.). cDNA was synthesized using the iScript cDNA synthesis kit (Bio-Rad Laboratories, Inc.) by RT of 2 µl total RNA. The CFX96 Real-time System (Bio-Rad Laboratories, Inc.) was used to perform RT-qPCR with SYBR Green Supermix (Bio-Rad Laboratories, Inc.). The extraction of total RNA, the synthesis of cDNA, and the steps of RT-qPCR were all performed according to the manufacturers\' instructions ([@b27-ol-0-0-11698]). The thermocycling conditions were: Denaturation at 95°C for 30 sec, annealing at 60°C for 30 sec, extension at 72°C for 60 sec, repeated for 30 cycles. Finally, the product was kept intact at 72°C for 5 min to complete the extension and stored at 4°C. The primer sequences used in the present study are presented in [Table SI](#SD1-ol-0-0-11698){ref-type="supplementary-material"}. The control gene was β-actin and the 2^−ΔΔCq^ method was used to calculate the mRNA expression relative to the control group ([@b30-ol-0-0-11698]).

### miRNA prediction and circRNA-miRNA interaction network analysis

TargetScan (v7.0) and miRanda (v3.3a) were used to identify potential miRNA targets of circRNAs ([@b14-ol-0-0-11698]). The Cloudseq software was used to analyze interactions between circRNA and miRNA; each circRNA has multiple miRNA binding sites. The construction of circRNA-miRNA networks was performed using Cytoscape (v3.1.0) software.

### Statistical analysis

Data analysis was performed using GraphPad Prism 7.0 (GraphPad Software, Inc.). Results are presented as the mean ± standard deviation from at least three independent experiments. A two-tailed Student\'s t-test was used to analyze the differences between the two groups. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Overview of circRNA expression profiles

Based on the results of the CCK-8 assay ([Fig. S1](#SD1-ol-0-0-11698){ref-type="supplementary-material"}), after a 2 Gy irradiation treatment for 48 hours, the cell viability of A549 was significantly reduced (P\<0.05). The total RNA of the control group A549 cells (0 Gy/48 h) and the irradiation group A549 cells (2 Gy/48 h) were extracted separately for RNAseq, three samples per group. The expression profiles of circRNA were first analyzed in the irradiated and non-irradiated A549 cells. A total of 1,875 circRNA targets was detected by RNAseq. A hierarchical clustering heatmap ([Fig. 1A](#f1-ol-0-0-11698){ref-type="fig"}) and volcano plots ([Fig. 1B](#f1-ol-0-0-11698){ref-type="fig"}) suggested that the expression levels of circRNA were clustered and distinguishable. A total of 67 significantly differentially expressed circRNAs in irradiated and non-irradiated A549 cells (fold change ≥2.0; P\<0.05) were identified. Of these, 30 circRNAs were significantly upregulated ([Table I](#tI-ol-0-0-11698){ref-type="table"}) and 37 were downregulated ([Table II](#tII-ol-0-0-11698){ref-type="table"}) \>2-fold in irradiated A549 cells, compared with non-irradiated A549 cells.

Of the 67 differentially expressed circRNAs, 64 were known circRNAs listed in circbase, and 3 were novel ([Fig. 1C](#f1-ol-0-0-11698){ref-type="fig"}). Most of the 67 identified circRNAs were \<2,000 nucleotides in length ([Fig. 1D](#f1-ol-0-0-11698){ref-type="fig"}). Based on structure, five categories of circRNAs were identified: i) Exonic circRNAs; ii) intronic circRNAs; iii) sense overlapping circRNAs; iv) intergenic circRNAs; and v) antisense circRNAs. Exonic circRNAs represented 83.6% (56/67) of all identified circRNAs, sense overlapping circRNAs were at 13.4% (9/67), and other circRNAs at 3% (2/67; [Fig. 1E](#f1-ol-0-0-11698){ref-type="fig"}). Sixty-six circRNAs were located on chromosomes, while one downregulated circRNA was located in the mitochondrial genome ([Fig. 1F](#f1-ol-0-0-11698){ref-type="fig"}).

### Predicted functions and pathways of differentially expressed circRNAs

The special RNA analysis software (DCC) was used to obtain the genomic location of circRNA target genes. In combination with the gene annotation in the circbase, the target genes of circRNAs were obtained. The functions and pathways of differentially expressed circRNAs were predicted by GO and KEGG analysis based on their corresponding target genes. GO enrichment analysis predicted the top 10 functional roles of target host genes according to BP, CC and MF ([Fig. 2](#f2-ol-0-0-11698){ref-type="fig"}). GO analysis suggested the target genes participated in multiple BPs related to human tumorigenesis, including 'cell morphogenesis involved in differentiation', 'neuron development' and 'chordate embryonic development'.

The KEGG enrichment analysis identified five pathways related to the upregulated circRNAs, the 'AGE-RAGE signaling pathway in diabetic complications', 'thyroid hormone signaling pathway', 'FoxO signaling pathway', 'protein processing in the endoplasmic reticulum' and 'RNA transport' ([Fig. 3A](#f3-ol-0-0-11698){ref-type="fig"}). The pathway analysis also indicated two pathways associated with downregulated circRNAs, namely the 'glutamatergic synapse' and the 'Hippo signaling pathway' ([Fig. 3B](#f3-ol-0-0-11698){ref-type="fig"}). The FOXO signaling pathway is presented as an example ([Fig. 3C](#f3-ol-0-0-11698){ref-type="fig"}). The FOXO signaling pathway was associated with several BPs, including 'cell cycle', 'apoptosis' and 'regulation of autophagy'.

### Validation of the accuracy of circRNA sequencing data by RT-qPCR

To validate the RNAseq data, the top 5 upregulated (excluding hsa_circ_0008278 due to its sequence length \>40,000 nucleotides) and downregulated circRNAs were selected based on P-value and fold change, and subjected to RT-qPCR. RT-qPCR demonstrated that hsa_circ_0003187, hsa_circ_0002174, hsa_circ_0070039, hsa_circ_0004270 and hsa_circ_0005591 expressions were significantly upregulated in irradiated cells compared with corresponding non-irradiated cells ([Fig. 4A](#f4-ol-0-0-11698){ref-type="fig"}). Moreover, the expression of hsa_circ_0001009, hsa_circ_0004815, hsa_circ_0096360, hsa_circ_0036627 and hsa_circ_0004524 were significantly downregulated in irradiated cells ([Fig. 4B](#f4-ol-0-0-11698){ref-type="fig"}). These 10 circRNA expression levels detected by RT-qPCR were consistent with RNAseq data, demonstrating the accuracy of high-throughput RNAseq results.

### circRNA-miRNA co-expression network

Potential interactions between the 10 validated circRNAs and microRNAs were theoretically predicted through conserved binding sites using miRanda and TargetScan analyses. All 10 circRNAs had complementary miRNA response elements. circRNA_0002174 and circRNA_0036627 were the two circRNAs with the largest number of predicted miRNA-binding sites among upregulated circRNAs and downregulated circRNAs, respectively ([Fig. 5](#f5-ol-0-0-11698){ref-type="fig"}; [Table III](#tIII-ol-0-0-11698){ref-type="table"}). These two circRNAs could be investigated to help resolve the molecular mechanisms of radiotherapy.

Discussion
==========

With the development of new computational methods and high-throughput sequencing, circRNA has been recognized as a stable and abundant form of RNA, and is presently regarded as an essential part of the non-coding RNA family ([@b31-ol-0-0-11698]). Previously, several studies demonstrated that circRNAs played a vital role in the pathophysiology of various diseases, with particular relevance in different types of cancer ([@b18-ol-0-0-11698],[@b32-ol-0-0-11698],[@b33-ol-0-0-11698]). Furthermore, circRNAs could promote cell proliferation, migration, invasion and metastasis in NSCLC ([@b20-ol-0-0-11698]--[@b22-ol-0-0-11698]). Moreover, previous studies have found that circRNA may play a major role in response to radiation ([@b23-ol-0-0-11698]). circRNA was significantly differently expressed in radioresistant esophageal cancer cells ([@b24-ol-0-0-11698]) and radioresistant HeLa cells ([@b25-ol-0-0-11698]). circRNA_014511 could affect the radiosensitivity of bone marrow mesenchymal stem cells by binding to miR-29b-2-5p ([@b26-ol-0-0-11698]). However, the functions and biological features of circRNAs in lung cancer radiotherapy remain poorly understood. In the present study, the expression levels of circRNAs in irradiated and non-irradiated A549 cells were determined by circRNA sequencing, to examine the possible underlying involvement of differentially expressed circRNAs in the mechanisms of lung cancer radiotherapy.

To the best of the authors\' knowledge, the present study was the first to identify differentially expressed circRNAs in irradiated A549 cells by examining junction reads. A549 cells received a 2 Gy irradiation dose and total RNA was collected after 48 h. This time interval was chosen because most of the radiation-related genes with high expression were strongly inhibited after 48 h, based on previous studies ([@b25-ol-0-0-11698],[@b34-ol-0-0-11698]). Among the total 1,875 identified circRNAs, 30 significantly upregulated circRNAs and 37 significantly downregulated circRNAs were detected in irradiated A549 cells. The expression levels of the top 5 upregulated and downregulated circRNAs were further validated by RT-qPCR, which were consistent with high-throughput sequencing data.

Differentially expressed circRNAs may regulate the transcription of several target genes in irradiated lung cancer cells. In order to further investigate the potential functions of circRNAs in irradiated A549 cells, GO and KEGG analyses were conducted. GO analysis was used to identify the BP, CC and MF of target genes. Previous studies demonstrated that irradiation can cause DNA strand breaks via different mechanisms ([@b35-ol-0-0-11698],[@b36-ol-0-0-11698]). Notably, irradiation induces DNA damage ([@b37-ol-0-0-11698]). The results of the present study suggested that the target genes associated with dysregulated circRNAs might be related to the regulation of DNA damage response ('signal transduction by p53 class mediator'). In addition, the present study also indicated that 'labyrinthine layer blood vessel development' was a notable BP term in response to irradiation. Similarly, Lee *et al* ([@b38-ol-0-0-11698]) had previously identified that vascular endothelial growth factor was highly expressed following irradiation, which might lead to rapid blood vessel development. 'Small conjugating protein binding' was also an important GO term. KEGG analysis identified several pathways associated with the upregulated and downregulated circRNAs identified in the present study. Among these pathways, the FOXO signaling pathway was identified. The FOXO signaling pathway was associated with several cellular functions in previous studies, including proliferation, apoptosis, inflammation migration, antitumor activities and metabolism through regulation of numerous transcriptional targets ([@b39-ol-0-0-11698],[@b40-ol-0-0-11698]). A further understanding of the function of these differentially expressed circular RNAs will help to understand the mechanisms associated with radiation damage.

Previous studies demonstrated that circRNAs could negatively regulate the effects of miRNAs, and promote the effects of endogenous mRNAs ([@b15-ol-0-0-11698],[@b41-ol-0-0-11698]). A single circRNA may regulate multiple miRNAs, thereby affecting several pathways. Zhao *et al* ([@b42-ol-0-0-11698]) suggested that ciRS-7 had \>60 well-known miR-7 binding sites, which is far more than any known linear RNA sponge. In the present study, a circRNA-miRNA interaction network was constructed to examine the biological role of circRNAs following irradiation. The network analysis suggested that two potential circRNAs (circRNA_0002174 and circRNA_0036627) might play an important role in the regulation of target miRNAs. Based on the characteristics of circRNAs, including structural stability, stable expression and tissue specificity, circRNAs could serve as a novel biomarker and therapeutic target for cancer treatment. Chen *et al* ([@b43-ol-0-0-11698]) suggested that circRNA epithelial stromal interaction 1 played a vital role as a prognostic marker in patients with triple-negative breast cancer. Nair *et al* ([@b44-ol-0-0-11698]) suggested that circRNAs might function as markers of cell proliferation in breast cancer. circPRKCI may serve as a potential therapeutic target for patients with lung adenocarcinoma ([@b45-ol-0-0-11698]). The present study demonstrated that differential expression of circRNAs in irradiated and non-irradiated A549 cells could be a critical marker of radiation-induced damage.

In conclusion, the preset study identified differentially expressed circRNAs and their target genes in irradiated A549 cells. The results of the present study suggested that circRNAs might play an important role in response to irradiation. The top 5 upregulated and downregulated circRNAs were validated; however, further investigation is required in order to examine the molecular functions of circRNAs in radiotherapy. Several potential circRNA-miRNA networks were predicted through bioinformatics analysis. These results warrant further investigation of the potential biological functions of circRNAs in lung cancer radiotherapy.
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![Characteristics of differentially expressed circRNAs were detected by high-throughput sequencing of IR and N A549 cells. (A) Expression heatmap of distinguishable and clustered circRNAs in IR and N cells. (B) Volcano plots of differentially expressed circRNAs in IR and N cells. Vertical line indicates a 2.0-fold (log2 scale) change; the horizontal line represents the P-value of 0.05 (−log10 scale). Red dots indicate the differentially expressed circRNAs with statistical significance. (C) Counts of upregulated and downregulated circRNAs. In total, 67 circRNAs were significantly differentially expressed between IR and N A549 cells (fold change ≥2.0; P\<0.05); of these, 30 circRNAs were significantly upregulated (red), 37 circRNAs were downregulated (yellow), and three circRNAs were novel (light red or light yellow). (D) Counts of differentially expressed circRNAs based on nucleotide length. (E) Counts of differentially expressed circRNAs based on five categories of circRNAs. (F) Counts of differentially expressed circRNAs based on chromosomal location. IR, irradiated; N, non-irradiated; circRNAs, circular RNAs; chr, chromosome.](ol-20-02-1557-g00){#f1-ol-0-0-11698}

![GO enrichment analysis. (A) Top 10 GO terms of upregulated circRNAs. (B) Top 10 GO terms of downregulated circRNAs. GO, Gene Ontology; circRNAs, circular RNAs.](ol-20-02-1557-g01){#f2-ol-0-0-11698}

![Kyoto Encyclopedia of Genes and Genomes enrichment analysis. (A) Pathways associated with upregulated circRNAs. (B) Pathways associated with downregulated circRNAs. (C) Representation of the FOXO signaling pathway. Orange nodes represent upregulated target genes. circRNAs, circular RNAs.](ol-20-02-1557-g02){#f3-ol-0-0-11698}

![Differentially expressed circRNAs verified by reverse transcription-quantitative PCR. (A) Expression levels of the top 5 upregulated circRNAs in two NSCLC cell lines. (B) Expression levels of the top 5 downregulated circRNAs in two NSCLC cell lines. Each assay was performed at least in triplicate. Differences between groups were analyzed using two-tailed Student\'s t-test. \*P\<0.05, \*\*P\<0.01 and \*\*\*P\<0.001 vs. respective normal cells. NSCLC, non-small cell lung cancer; circRNAs, circular RNAs.](ol-20-02-1557-g03){#f4-ol-0-0-11698}

![circRNA-miRNA interaction network. Network was constructed using the top 5 upregulated and downregulated circRNAs (yellow nodes) and their first 10 complementary binding miRNAs (green nodes) using Cytoscape software. circRNAs, circular RNAs; miRNA, microRNA.](ol-20-02-1557-g04){#f5-ol-0-0-11698}

###### 

Upregulated circRNAs in irradiated A549 cells, compared with non-irradiated A549 cells.

  circRNA            Log FC   P-value   Chromosomal location          Gene name
  ------------------ -------- --------- ----------------------------- ----------------------
  hsa_circ_0008278   4.423    0.003     Chr2: 120885264−120932580+    EPB41L5
  hsa_circ_0003187   4.035    0.015     Chr4: 146767108−146770713−    ZNF827
  hsa_circ_0002174   4.029    0.01      Chr3: 195686054−195686957−    GSE61474_XLOC_045249
  hsa_circ_0070039   4.023    0.007     Chr4: 77055328−77065626−      NUP54
  hsa_circ_0004270   4.020    0.011     Chr1: 108690901−108703915−    SLC25A24
  hsa_circ_0005591   3.794    0.028     Chr12: 110566755−110570441+   IFT81
  hsa_circ_0029605   3.789    0.028     Chr13: 20235838−20244503+     MPHOSPH8
  hsa_circ_0001865   3.787    0.028     Chr9: 86292642−86293514−      UBQLN1
  hsa_circ_0002874   3.780    0.013     Chr9: 4286038−4286523−        GLIS3
  hsa_circ_0011218   3.506    0.042     Chr1: 31413998−31414970−      PUM1
  hsa_circ_0030632   3.499    0.042     Chr13: 96636058−96651561−     UGGT2
  hsa_circ_0005579   3.499    0.042     Chr2: 36623757−36691798+      CRIM1
  hsa_circ_0088239   3.497    0.043     Chr9: 119093523−119097353+    PAPPA
  hsa_circ_0105573   3.497    0.043     Chr16: 53472928−53504834+     RBL2
  hsa_circ_0099569   3.497    0.043     Chr12:95663815-95681633+      VEZT
  Novel              3.497    0.043     Chr6:154749262-154763424−     CNKSR3
  hsa_circ_0044158   3.490    0.036     Chr17:43197692-43198739−      PLCD3
  hsa_circ_0005238   3.490    0.043     Chr21:17205667-17214859+      USP25
  hsa_circ_0136108   3.490    0.043     Chr8:19442677-19459376−       CSGALNACT1
  hsa_circ_0003677   3.488    0.03      Chr12:117365828-117402659+    FBXW8
  hsa_circ_0066776   3.485    0.043     Chr3:110830877-110845182+     PVRL3
  hsa_circ_0009061   3.485    0.043     Chr1:23356962-23377013+       KDM1A
  hsa_circ_0001603   3.482    0.043     Chr6:42559889-42562042+       UBR2
  hsa_circ_0000199   3.479    0.037     Chr1:243708812-243736350−     AKT3
  hsa_circ_0004820   3.475    0.044     Chr2:183993015-183995273+     NUP35
  hsa_circ_0002224   3.475    0.044     Chr10:51374370-51387763+      TIMM23B
  hsa_circ_0053317   3.468    0.044     Chr2:28460069-28464260+       BRE
  hsa_circ_0000378   2.792    0.019     Chr12:12397196-12397589−      LRP6
  hsa_circ_0001190   2.446    0.046     Chr21:38792601-38794168+      DYRK1A
  hsa_circ_0005456   2.422    0.047     Chr9:118949433-118950495+     PAPPA

circRNA, circular RNA; FC, fold change; Chr, chromosome.

###### 

Downregulated circRNAs in irradiated A549 cells, compared with non-irradiated A549 cells.

  circRNA            Log FC   P-value   Chromosomal location          Gene name
  ------------------ -------- --------- ----------------------------- -----------
  hsa_circ_0001009   −4.213   0.005     Chr2: 58449077−58459247−      FANCL
  hsa_circ_0004815   −3.972   0.013     Chr12: 42745687−42792796+     PPHLN1
  hsa_circ_0096360   −3.769   0.025     Chr11: 70505933−70507783−     SHANK2
  hsa_circ_0036627   −3.767   0.025     Chr15: 85656608−85669605+     PDE8A
  hsa_circ_0004524   −3.750   0.026     Chr3: 138289160−138291774−    CEP70
  hsa_circ_0006834   −3.740   0.031     Chr2: 120885264−120932576+    EPB41L5
  hsa_circ_0006284   −3.740   0.031     Chr11: 12883797−12886447+     TEAD1
  hsa_circ_0001345   −3.736   0.015     Chr3: 142455221−142467302+    TRPC1
  hsa_circ_0127359   −3.736   0.031     Chr4: 95796982−95820201+      BMPR1B
  hsa_circ_0098537   −3.736   0.031     Chr12: 41408030−41423021+     CNTN1
  hsa_circ_0005925   −3.503   0.044     Chr7: 99952766−99953427+      PILRB
  hsa_circ_0002658   −3.479   0.045     Chr3: 15726733−15731727−      ANKRD28
  hsa_circ_0116480   −3.479   0.045     Chr22: 32664275−32669494+     G053490
  hsa_circ_0124903   −3.479   0.045     Chr4: 103644028−103651893−    MANBA
  hsa_circ_0000606   −3.479   0.045     Chr15: 60734615−60737990−     ICE2
  hsa_circ_0001977   −3.466   0.046     Chr20: 17928130−17937681−     SNX5
  Novel              −3.464   0.040     ChrM: 13298−13449+            MTND5
  Novel              −3.464   0.046     Chr20: 45801355−45809584+     EYA2
  hsa_circ_0004844   −3.460   0.033     ChrX: 2871184−2876476−        ARSE
  hsa_circ_0005062   −3.455   0.047     Chr9: 710804−713464+          KANK1
  hsa_circ_0002714   −3.453   0.047     Chr7: 80418622−80435074−      SEMA3C
  hsa_circ_0058495   −3.453   0.046     Chr2: 227729320−227779067+    RHBDD1
  hsa_circ_0003692   −3.453   0.046     Chr3: 171969050−172028671+    FNDC3B
  hsa_circ_0078299   −3.453   0.041     Chr6: 151669846−151674887+    AKAP12
  hsa_circ_0101802   −3.442   0.047     Chr14: 39648295−39648666+     PNN
  hsa_circ_0000532   −3.440   0.047     Chr14: 45564424−45566208+     PRPF39
  hsa_circ_0006501   −3.431   0.048     Chr7: 101870647−101870949+    CUX1
  hsa_circ_0006021   −3.418   0.048     Chr1: 235582788−235597595+    TBCE
  hsa_circ_0123217   −3.418   0.048     Chr3: 196214270−196215554−    RNF168
  hsa_circ_0004532   −3.418   0.048     Chr17: 12011107−12016677+     MAP2K4
  hsa_circ_0006668   −3.407   0.049     Chr12: 51442817−51451911+     LETMD1
  hsa_circ_0008153   −2.549   0.034     Chr15: 63845914−63855207+     USP3
  hsa_circ_0093688   −2.333   0.016     Chr10: 4872867−4950612+       AKR1E2
  hsa_circ_0000443   −1.733   0.015     Chr12: 116668338−116675510−   MED13L
  hsa_circ_0001460   −1.669   0.045     Chr4:178274462-178281831+     NEIL3
  hsa_circ_0112879   −1.497   0.009     Chr1:247319708-247323115−     ZNF124
  hsa_circ_0005332   −1.152   0.026     Chr3:114069121-114070725−     ZBTB20

circRNA, circular RNA; FC, fold change; Chr, chromosome.

###### 

A total of 10 validated circRNA and their miRNA targets.

  circRNA            Chromosomal location          No. of miRNA targets
  ------------------ ----------------------------- ----------------------
  hsa_circ_0036627   Chr15: 85656608−85669605+     378
  hsa_circ_0002174   Chr3: 195686054−195686957−    276
  hsa_circ_0004815   Chr12: 42745687−42792796+     274
  hsa_circ_0070039   Chr4: 77055328−77065626−      229
  hsa_circ_0004270   Chr1: 108690901−108703915−    164
  hsa_circ_0004524   Chr3: 138289160−138291774−    121
  hsa_circ_0003187   Chr4: 146767108−146770713−    114
  hsa_circ_0001009   Chr2: 58449077−58459247−      103
  hsa_circ_0005591   Chr12: 110566755−110570441+   66
  hsa_circ_0096360   Chr11: 70505933−70507783−     60

circRNA, circular RNA; Chr, chromosome, miRNA, microRNA.

[^1]: Contributed equally
